• Citer

Molecular markers, molecular-targeted therapies and taxanes: how to integrate the progress into clinical research and practice for the management of head and neck cancers.

par Awada, Ahmad ;Lalami, Yassine
Référence Current opinion in oncology, 17, 3, page (209-211)
Publication Publié, 2005-05

Article révisé par les pairs

• Détails

Titre:	Molecular markers, molecular-targeted therapies and taxanes: how to integrate the progress into clinical research and practice for the management of head and neck cancers.
Auteur:	Awada, Ahmad; Lalami, Yassine
Informations sur la publication:	Current opinion in oncology, 17, 3, page (209-211)
Statut de publication:	Publié, 2005-05
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Antineoplastic Agents -- therapeutic use
	Carcinoma, Squamous Cell -- diagnosis
	Carcinoma, Squamous Cell -- drug therapy
	Drug Delivery Systems
	Evidence-Based Medicine
	Head and Neck Neoplasms -- diagnosis
	Head and Neck Neoplasms -- drug therapy
	Humans
	Medical Oncology -- trends
	Neoplasm Staging
	Taxoids -- therapeutic use
	Tumor Markers, Biological -- genetics
Note générale:	Editorial
	Review
	SCOPUS: ed.j
Langue:	Anglais
Identificateurs:	urn:issn:1040-8746
	info:doi/10.1097/01.cco.0000156984.81195.46
	info:pii/00001622-200505000-00002
	info:scp/17844386832
	info:pmid/15818162